Showing results (21-30 of 499) with videos related to
Sort By:
Pageof 50
Expert Opinion on Biological Therapy|September 13, 2016
From therapeutic antibodies to chimeric antigen receptors (CARs): making better CARs based on antigen-binding domainYanling Wu, Shibo Jiang, Tianlei YingTrends in Immunology|February 1, 2024
SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequencesXinling Wang, Lu Lu, Shibo JiangCurrent Pharmaceutical Design|February 3, 2007
HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compoundsShuwen Liu, Shuguang Wu, Shibo JiangCell Chemical Biology|March 30, 2022
Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodiesShibo Jiang, Alexander Tuzikov, Alexander AndrianovPeptides|January 7, 2004
Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitorsShuwen Liu, Qian Zhao, Shibo JiangAdvances in Experimental Medicine and Biology|April 12, 2022
Virus Entry Inhibitors: Past, Present, and FutureShan Su, Wei Xu, Shibo JiangAdvances in Experimental Medicine and Biology|April 12, 2022
Peptide-Based HIV Entry InhibitorsJing Pu, Qian Wang, Shibo JiangExpert Review of Vaccines|April 29, 2014
Current advancements and potential strategies in the development of MERS-CoV vaccinesNaru Zhang, Shibo Jiang, Lanying DuEmerging Infectious Diseases|July 19, 2005
SARS vaccine developmentShibo Jiang, Yuxian He, Shuwen LiuCell & Bioscience|March 21, 2013
Controlling HIV sexual transmission: a major challenge for China's new leadershipShibo Jiang, Weihua Li, Lu LuPageof 50